Inhaler Corticosteroid Device Market Size was valued at USD 616.09 Mn in 2023 and is predicted to reach USD 886.4 Mn by 2031 at a 4.6% CAGR during the forecast period for 2024-2031.
Asthma is a disease of the entire respiratory tract, including large, intermediate, and small airways. Asthma leads to inflammation and obstruction of the respiratory tract. Hence, this has led to significant interest in the inhaler device, which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. The inhaler corticosteroid device market is witnessing steady growth driven by the increasing prevalence of respiratory conditions like asthma and COPD globally. Technological advancements in device design, materials, and features enhance effectiveness and patient adherence. Expanding into emerging economies and rising healthcare awareness fuels market demand.
However, the high cost of treatment, misuse of funding, and lack of awareness are some of the factors that could be improved in the growth of the market during the forecast period—the patent expirations leading to generic competition impact pricing and market share. Regulatory updates emphasize safety, efficacy, and environmental sustainability. Partnerships aim to accelerate innovation and market penetration. Focusing on patient education and support and sustainability initiatives contribute to market dynamics. Despite challenges posed by the COVID-19 pandemic, ongoing research and development efforts promise continued market evolution.
The inhaler corticosteroid device market is segmented on the basis of steroid types-beclomethasone, dipropionate, budesonide, fluticasone inhaler powder, mometasone. By application- asthma, COPD (Chronic Obstructive Pulmonary Disease), others, by end-user –hospitals and clinics, academic and research institutes, respiratory care center.
The COPD (Chronic Obstructive Pulmonary Disease) segment holds significant sway in the inhaler corticosteroid device market due to the high prevalence of COPD worldwide. Inhaler corticosteroid devices are crucial in managing COPD symptoms, including inflammation and airway constriction. With COPD being a leading cause of morbidity and mortality globally, the demand for effective treatment options remains robust. Inhaler corticosteroid devices offer targeted delivery of medication directly to the lungs, providing symptomatic relief and improving the quality of life for COPD patients. As a result, the COPD segment emerges as a major contributor to the overall market growth and revenue.
The hospitals and clinics segment in the inhaler corticosteroid device market is experiencing rapid growth due to several factors. Firstly, the increasing prevalence of respiratory diseases necessitates frequent visits to healthcare facilities for diagnosis and treatment. Secondly, hospitals and clinics often serve as primary points of care where patients receive prescriptions for inhaler corticosteroid devices. Additionally, advancements in healthcare infrastructure and the availability of specialized respiratory care services in these settings contribute to the segment's growth. Moreover, healthcare professionals in hospitals and clinics play a crucial role in educating patients about proper inhaler usage, further driving demand within this segment.
The North American inhaler corticosteroid device market commands a substantial revenue share for several reasons. Firstly, North America has a high prevalence of respiratory diseases such as asthma and COPD, driving demand for inhaler corticosteroid devices. Secondly, the region boasts advanced healthcare infrastructure and a well-established pharmaceutical industry, facilitating easy access to these devices. Additionally, favorable reimbursement policies and robust regulatory frameworks ensure the widespread adoption of inhaler corticosteroid devices. Furthermore, ongoing research and development activities and technological innovations in the region contribute to market growth. Overall, these factors consolidate North America's position as a key player in the inhaler corticosteroid device market.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 616.09 Mn |
|
Revenue Forecast In 2031 |
USD 886.4 Mn |
|
Growth Rate CAGR |
CAGR of 4.6% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Steroid Types, By Application, By End-user and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Boehringer Ingelheim International GmbH., AstraZeneca, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Amgen Inc., Aurobindo Pharma, Eli Lilly and Company, Cipla Inc. and Sumitomo Corporation. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Inhaler Corticosteroid Device Market Snapshot
Chapter 4. Global Inhaler Corticosteroid Device Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Steroid Types Estimates & Trend Analysis
5.1. by Steroid Types & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Steroid Types:
5.2.1. Beclomethasone Dipropionate
5.2.2. Budesonide
5.2.3. Fluticasone Inhaler Powder
5.2.4. Mometasone
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Asthma
6.2.2. COPD (Chronic Obstructive Pulmonary Disease)
6.2.3. Others
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
7.2.1. Hospitals and Clinics
7.2.2. Academic and Research Institutes
Chapter 8. Inhaler Corticosteroid Device Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.1.2. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.1.3. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.1.4. North America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.2.2. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.2.3. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.2.4. Europe Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.3.2. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.3.3. Asia-Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.3.4. Asia Pacific Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.4.2. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.4.3. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.4.4. Latin America Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Steroid Types, 2019-2031
8.5.2. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.5.3. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
8.5.4. Middle East & Africa Inhaler Corticosteroid Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. -La Roche Ltd. (Switzerland)
9.2.3. Pfizer Inc.
9.2.4. GlaxoSmithKline plc
9.2.5. Novartis AG
9.2.6. Mylan N.V.
9.2.7. Teva Pharmaceutical Industries Ltd.
9.2.8. Sanofi
9.2.9. Boehringer Ingelheim International GmbH.
9.2.10. AstraZeneca
9.2.11. F. Hoffmann-La Roche Ltd.
9.2.12. Bristol-Myers Squibb Company
9.2.13. Amgen Inc.
9.2.14. Aurobindo Pharma
9.2.15. Eli Lilly and Company
9.2.16. Cipla Inc.
9.2.17. Sumitomo Corporation
9.2.18. Other Prominent Players
Global Inhaler Corticosteroid Device Market- By Steroid Types
Global Inhaler Corticosteroid Device Market- By Application
Global Inhaler Corticosteroid Device Market- By End-User
Global Inhaler Corticosteroid Device Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
